beta-tocotrienol : A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 5 and 8 and a farnesyl chain at position 2. It has been isolated from various cultivars of wheat.
ID Source | ID |
---|---|
PubMed CID | 5282348 |
CHEBI ID | 33275 |
SCHEMBL ID | 66599 |
SCHEMBL ID | 16430159 |
MeSH ID | M0218843 |
Synonym |
---|
BIDD:PXR0058 |
.epsilon.-tocopherol |
(2r)-3,4-dihydro-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2h-1-benzopyran-6-ol |
CHEBI:33275 |
(2r)-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2h-chromen-6-ol |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2r)- |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2r)- (9ci) |
3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3,7,11-trienyl)-2h-1-benzopyran-6-ol |
epsilon-tocopherol |
beta-tocotrienol |
d-beta-tocotrienol |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, [r-(e,e)]- |
490-23-3 |
6-chromanol,2,5,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)- (8ci) |
tocotrienol, beta |
2r,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2h-chromen-6-ol |
LMPR02020055 |
(2r)-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol |
einecs 207-708-0 |
chh810zm8c , |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-((3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl)-, (2r)- |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-((3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (2r)- |
unii-chh810zm8c |
[r-(e,e)]-3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2- ((3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl)-, (2r)- |
.beta.-tocotrienol |
j37.066e , |
d-.beta.-tocotrienol |
.epsilon.-tokoferol |
beta-tocotrienol [who-dd] |
.beta.-tocotrienol [mi] |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2- ((3e,7e)-4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (2r)- |
2h-1-benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (r-(e,e))- |
SCHEMBL66599 |
tocotrienol, 5,8-dimethyl |
a-tocotrienol |
SCHEMBL16430159 |
beta-tocotrienol, analytical standard |
Q171542 |
2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol |
A934798 |
(2r)-2,5,8-trimethyl-2-[(3e,7e)-4,8,12-trimethyl-3,7,11-tridecatr ien-1-yl]-6-chromanol |
MS-27089 |
DTXSID50883401 |
HY-108693 |
CS-0029986 |
d-beta- tocotrienol |
beta -tocotrienol |
AKOS040744870 |
Excerpt | Relevance | Reference |
---|---|---|
" The tocotrienol-rich fraction (TRF) of palm oil inhibited growth of MCF7 cells in both the presence and absence of estradiol with a nonlinear dose-response but such that complete suppression of growth was achieved at 8 microg/mL." | ( Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Darbre, P; Dils, R; Nesaretnam, K; Stephen, R, 1998) | 0.3 |
Role | Description |
---|---|
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
antineoplastic agent | A substance that inhibits or prevents the proliferation of neoplasms. |
apoptosis inducer | Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
tocotrienol | A tocol in which the hydrocarbon chain at position 2 contains three double bonds. |
vitamin E | Any member of a group of fat-soluble chromanols that exhibit biological activity against vitamin E deficiency. The vitamers in this class consists of a chroman-6-ol core which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. The major function of vitamin E is to act as a natural antioxidant by scavenging free radicals and molecular oxygen. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
vitamin E biosynthesis (tocotrienols) | 1 | 13 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 5 (27.78) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 6 (33.33) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.28) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |